OCULAR DEVELOPMENT IN INFANCY/EARLY CHILDHOOD
婴儿期/幼儿期的视力发育
基本信息
- 批准号:2684589
- 负责人:
- 金额:$ 26.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-04-01 至 2002-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The most rapid phase of post-natal ocular growth occurs during the first
years of life. Although much is known about the development of refractive
error in infancy, there is little biometric data available on the ocular
components during either infancy or early childhood. The course of infant
refractive and component development can shed light on both basic
mechanisms of eye growth as well as possible links with juvenile refractive
error. Animal studies in chicken and primate models suggests that the eye
is sensitive to the sign and magnitude of refractive error, with the eye
adjusting its rate of growth to reduce these errors. Recent longitudinal
studies of infant refraction have found associations between non-
cycloplegic retinoscopy in infancy and in later childhood. Longitudinal
refractive and biometric data from infancy will make it possible to examine
the responsiveness of the eye to initial refractive error, the components
responsible for emmetropization, and how component and refractive error,
the components responsible for emmetropizatin, and how component and
refractive development in the first years of life are related to ocular
growth in childhood.
The Berkely Infant Biometry Study (BIBS) is a five-year longitudinal study
of the ocular components in infants and toddlers aged three months to three
years. Its goal is to determine what changes occur in the eyes of young
children during this time period and how these changes fit into a model of
emmetropization that is either active or passive. Examination for
component development in infants as a function of initial refractive error
and as a function of the degree of emmetropization will indicate which
components underlie ametropia and emmetropization. We measure refractive
error, including astigmatism, corneal curvature in two meridians, anterior
chamber depth, crystalline lens thickness and surface curvatures in two
meridians, vitreous chamber depth, and axial length. We will determine how
changes in the axial length, corneal curvature, and crystalline lens
curvatures are coordinated during this rapid growth phase. We will
investigate which ocular components-cornea or lens-are responsible for the
previously reported astigmatism in infancy and its disappearance in early
childhood.
出生后眼睛生长最快的阶段发生在第一个阶段,
多年的生活。 尽管对屈光不正的发展有很多了解,
在婴儿期的错误,有一个小的生物统计数据上的眼睛
在婴儿期或幼儿期使用。 婴儿的过程
折射和成分的发展可以揭示这两个基本的
眼睛生长的机制以及与青少年屈光不正的可能联系
错误. 在鸡和灵长类动物模型中进行的动物研究表明,
对屈光不正的符号和大小敏感,
调整其增长率以减少这些误差。 近期纵向
对婴儿屈光的研究发现,
婴儿期和儿童后期的散瞳视网膜检影。纵向
婴儿期的屈光和生物特征数据将使检查成为可能,
眼睛对初始屈光不正的反应性,
负责正视化,以及如何组成和屈光不正,
负责正视化成分,以及成分和
在生命的最初几年屈光发展与眼
童年的成长
伯克利婴儿生物统计学研究(BIBS)是一项为期五年的纵向研究,
三个月至三岁的婴幼儿的眼部成分
年 它的目标是确定年轻人的眼睛会发生什么变化,
儿童在这段时间内,以及这些变化如何适应一个模型,
主动或被动的正视化。 考试
作为初始屈光不正函数的婴儿成分发育
作为正视化程度的函数,
成分是屈光不正和正视化的基础。 我们测量折射率
误差,包括散光、两个子午线的角膜曲率、前
腔室深度、晶体透镜厚度和表面曲率
子午线、玻璃体腔深度和眼轴长度。 我们将决定如何
眼轴长度、角膜曲率和晶状体透镜的变化
在这个快速生长阶段,曲率是协调的。我们将
研究哪些眼部成分-角膜或晶状体-负责
先前报道的婴儿期散光和早期散光的消失
童年.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald O. Mutti其他文献
Ocular component growth in children with persistent hyperopia
- DOI:
10.1016/j.jaapos.2012.12.078 - 发表时间:
2013-02-01 - 期刊:
- 影响因子:
- 作者:
Simone L. Li;Vidhya Subramanian;Reed M. Jost;Donald O. Mutti;Eileen E. Birch - 通讯作者:
Eileen E. Birch
Predicting the onset of myopia in children: results from the CLEERE study
- DOI:
10.1186/s12886-021-02036-9 - 发表时间:
2021-07-14 - 期刊:
- 影响因子:1.700
- 作者:
Donald O. Mutti;Lisa A. Jordan;Karla Zadnik - 通讯作者:
Karla Zadnik
Donald O. Mutti的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald O. Mutti', 18)}}的其他基金
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Clinical Center
近视进展及后果的检查以及软性多焦点隐形眼镜近视控制的机制 - 临床中心
- 批准号:
10240451 - 财政年份:2014
- 资助金额:
$ 26.94万 - 项目类别:
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Clinical Center
近视进展及后果的检查以及软性多焦点隐形眼镜近视控制的机制 - 临床中心
- 批准号:
10382456 - 财政年份:2014
- 资助金额:
$ 26.94万 - 项目类别:
Soft Bifocal Contact Lens Myopia Control - Clincal Center
软双焦点隐形眼镜近视控制 - 临床中心
- 批准号:
8609228 - 财政年份:2014
- 资助金额:
$ 26.94万 - 项目类别:
Examination of Myopia Progression and Consequences and Mechanism of Soft Multifocal Contact Lens Myopia Control - Clinical Center
近视进展及后果的检查以及软性多焦点隐形眼镜近视控制的机制 - 临床中心
- 批准号:
10606492 - 财政年份:2014
- 资助金额:
$ 26.94万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 26.94万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 26.94万 - 项目类别: